XTL Biopharmaceuticals Ltd ADR (XTLB) — Cash Flow Quality Index
XTL Biopharmaceuticals Ltd ADR (XTLB) has a Cash Flow Quality Index of 0.04x as of December 2021. Operating cash flow of $79.00K is below net income of $2.10 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore XTL Biopharmaceuticals Ltd ADR cash conversion from operations to assess how effectively this company generates cash.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
XTL Biopharmaceuticals Ltd ADR Cash Flow Quality Index (2009–2021)
Historical Cash Flow Quality Index for XTL Biopharmaceuticals Ltd ADR across 3 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check how aggressively does XTL Biopharmaceuticals Ltd ADR reinvest cash to assess the company's total reinvestment commitment from operating cash flow.
Annual Cash Flow Quality Index for XTL Biopharmaceuticals Ltd ADR (2009–2021)
Year-by-year earnings quality comparison for XTL Biopharmaceuticals Ltd ADR. For live market cap and the full company financial profile, see XTL Biopharmaceuticals Ltd ADR market capitalisation.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2021 | -2.41x | $-1.05 Million | $435.00K | ▼ -782.4% |
| 2018 | -0.27x | $-816.00K | $2.99 Million | ▲ +71.6% |
| 2009 | -0.96x | $-2.49 Million | $2.59 Million | — |